Evolution of AF6-RAS association and its implications in mixed-lineage leukemia
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Elucidation of activation mechanisms governing protein fusions is essential for therapeutic development. MLL undergoes rearrangement with numerous partners, including a recurrent translocation fusing the epigenetic regulator to a cytoplasmic RAS effector, AF6/afadin. We show here that AF6 employs a non-canonical, evolutionarily conserved α-helix to bind RAS, unique to AF6 and the classical RASSF effectors. Further, all patients with MLL-AF6 translocations express fusion proteins missing only this helix from AF6, resulting in exposure of hydrophobic residues that induce dimerization. We provide evidence that oligomerization is the dominant mechanism driving oncogenesis from rare MLL translocation partners and employ our mechanistic understanding of MLL-AF6 to examine how dimers induce leukemia. Proteomic data resolve association of dimerized MLL with gene expression modulators, and inhibiting dimerization disrupts formation of these complexes while completely abrogating leukemogenesis in mice. Oncogenic gene translocations are thus selected under pressure from protein structure/function, underscoring the complex nature of chromosomal rearrangements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ProteoWizard: open source software for rapid proteomics tools development
Kessner, D., Chambers, M., Burke, R., Agus, D., & Mallick, P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn323 · Cited by 2,024
The impact of translocations and gene fusions on cancer causation
Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Basavapathruni, A., Jin, L., Boriack-Sjodin, P. A., Allain, C. J., Klaus, C. R., Raimondi, A., Scott, M. P., et al. (2013) · Blood · doi:10.1182/blood-2013-04-497644 · Cited by 722 · cited 3×
“For retroviral expression of MLL fusion proteins, MLL-AF6NCR (MLL residues 1–1395 fused to AF6 residues 35–348) and FLAG-AF6NCR (35-348) cloned into murine stem cell virus (MSCV) constructs were kindly provided by Michael Cleary15.”
MethodPharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
Grebien, F., Vedadi, M., Getlik, M., Giambruno, R., Grover, A., Avellino, R., Skucha, A., Vittori, S., Kuznetsova, E., Smil, D., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1859 · Cited by 284 · cited 3×
“For retroviral expression of MLL fusion proteins, MLL-AF6NCR (MLL residues 1–1395 fused to AF6 residues 35–348) and FLAG-AF6NCR (35-348) cloned into murine stem cell virus (MSCV) constructs were kindly provided by Michael Cleary15.”
MethodNMR-based functional profiling of RASopathies and oncogenic RAS mutations
Smith, M. J., Neel, B. G., & Ikura, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218173110 · Cited by 257 · cited 3×
“For retroviral expression of MLL fusion proteins, MLL-AF6NCR (MLL residues 1–1395 fused to AF6 residues 35–348) and FLAG-AF6NCR (35-348) cloned into murine stem cell virus (MSCV) constructs were kindly provided by Michael Cleary15.”
MethodSelf-citationProHits: integrated software for mass spectrometry–based interaction proteomics
Liu, G., Zhang, J., Larsen, B., Stark, C., Breitkreutz, A., Lin, Z.-Y., Breitkreutz, B.-J., Ding, Y., Colwill, K., Pasculescu, A., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1010-1015 · Cited by 243
Self-citationImmunocytochemistry reveals RANKL expression of myeloma cells
Sezer, O., Heider, U., Jakob, C., Zavrski, I., Eucker, J., Possinger, K., Sers, C., & Krenn, V. (2002) · Blood · doi:10.1182/blood-2002-01-0148 · Cited by 110
Integrated RAS signaling defined by parallel NMR detection of effectors and regulators
Smith, M. J., & Ikura, M. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1435 · Cited by 87
Self-citation
Cited by
Pantsar, T., Rissanen, S., Dauch, D., Laitinen, T., Vattulainen, I., & Poso, A. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006458 · Cited by 85
Structure of the DOCK2−ELMO1 complex provides insights into regulation of the auto-inhibited state
Chang, L., Yang, J., Jo, C. H., Boland, A., Zhang, Z., McLaughlin, S. H., Abu-Thuraia, A., Killoran, R. C., Smith, M. J., Côté, J.-F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17271-9 · Cited by 59
Self-citation(2023) · doi:10.1016/j.str.2023.04.007 · Cited by 6
McParland, E. D., Gurley, N. J., Wolfsberg, L. R., Butcher, T. A., Bhattarai, A., Jensen, C. C., Johnson, R. I., Slep, K. C., & Peifer, M. (2024) · Journal of Cell Science · doi:10.1242/jcs.263546 · Cited by 6
Hay, I. M., Mulholland, K. E., Lai, T., Graham, S. C., Sharpe, H. J., & Deane, J. E. (2022) · eLife · doi:10.7554/elife.79855 · Cited by 3
Metadata
- Authors
- Smith, M. J., Ottoni, E., Ishiyama, N., Goudreault, M., Haman, A., Meyer, C., Tucholska, M., Gasmi-Seabrook, G., Menezes, S., Laister, R. C., Minden, M. D., Marschalek, R., Gingras, A.-C., Hoang, T., & Ikura, M.
- Venue
- Nature Communications
- Published
- 2017-10-23
- Volume
- 8
- Issue
- 1
- Pages
- 1099-1099
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2766330359
- Cited by
- 27
- References
- 8
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evolution of AF6-RAS association and its implications in mixed-lineage leukemia. https://app.cochat.ai/papers/10.1038/s41467-017-01326-5
- The paper
- Smith, M. J., Ottoni, E., Ishiyama, N., Goudreault, M., Haman, A., Meyer, C., Tucholska, M., Gasmi-Seabrook, G., Menezes, S., Laister, R. C., Minden, M. D., Marschalek, R., Gingras, A.-C., Hoang, T., & Ikura, M. (2017). Evolution of AF6-RAS association and its implications in mixed-lineage leukemia. Nature Communications. https://doi.org/10.1038/s41467-017-01326-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.